Browsing: Pfizer

Protalix signs $280m Brazilian Gaucher deal

Pfizer will waive its commercialization rights on the seven year deal for Gaucher treatment Uplyso for $12.5 million annually. Protalix Biotherapeutics Inc. (AMEX:PLX; TASE: PLX) announced today that it has entered into a


Read More